Literature DB >> 11077441

Tel induces a G1 arrest and suppresses Ras-induced transformation.

L V Rompaey1, M Potter, C Adams, G Grosveld.   

Abstract

The Tel gene is a major target of translocations in leukemia and loss of heterozygosity is regularly observed for the non-translocated allele, thus supporting the notion that Tel is a tumor suppressor. Most tumor suppressors influence cellular proliferation, differentiation and cell death and thereby prevent oncogenic transformation and genetic instability. We found that overexpression of Tel retards proliferation of many cell types, primary cells and immortalized cells, by inducing a G1 arrest. Tel's block of cellular proliferation is rescued by high seeding densities. Furthermore, Tel suppressed Ras-mediated colony growth in soft agar and tumor formation in nude mice. The Pointed and DNA binding (DB) domains of Tel were required for all Tel-induced phenotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077441     DOI: 10.1038/sj.onc.1203899

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation.

Authors:  Kazuhiro Maki; Honoka Arai; Kazuo Waga; Ko Sasaki; Fumihiko Nakamura; Yoichi Imai; Mineo Kurokawa; Hisamaru Hirai; Kinuko Mitani
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

2.  TEL/ETV6 binds to corepressor KAP1 via the HLH domain.

Authors:  Yuka Nakamura; Tetsuya Yamagata; Kazuhiro Maki; Ko Sasaki; Issay Kitabayashi; Kinuko Mitani
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

3.  Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor.

Authors:  Lauren D Wood; Brenda J Irvin; Giuseppina Nucifora; K Scott Luce; Scott W Hiebert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

4.  ETV6-related thrombocytopenia and leukemia predisposition.

Authors:  Jorge Di Paola; Christopher C Porter
Journal:  Blood       Date:  2019-06-27       Impact factor: 22.113

5.  The ETS factor TEL2 is a hematopoietic oncoprotein.

Authors:  Cintia Carella; Mark Potter; Jacqueline Bonten; Jerold E Rehg; Geoffrey Neale; Gerard C Grosveld
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

6.  Low-level expression of ETV6/TEL in patients with Myelodysplastic syndrome.

Authors:  Tetsuya Yamagata; Yuka Nakamura; Kinuko Mitani
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

7.  Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.

Authors:  Meilin Wang; Dongying Gu; Mulong Du; Zhi Xu; Suzhan Zhang; Lingjun Zhu; Jiachun Lu; Rui Zhang; Jinliang Xing; Xiaoping Miao; Haiyan Chu; Zhibin Hu; Lei Yang; Cuiju Tang; Lei Pan; Haina Du; Jian Zhao; Jiangbo Du; Na Tong; Jielin Sun; Hongbing Shen; Jianfeng Xu; Zhengdong Zhang; Jinfei Chen
Journal:  Nat Commun       Date:  2016-05-05       Impact factor: 14.919

8.  Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.

Authors:  Yuan-Chin Tsai; Tao Zeng; Wassim Abou-Kheir; Hsiu-Lien Yeh; Juan Juan Yin; Yi-Chao Lee; Wei-Yu Chen; Yen-Nien Liu
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.